Skip to main content

March 2022

CORP 2022 - 024 - Information in relation to contact centre contracts at Velindre
CORP 2022 - 024 - Information in relation to contact centre contracts at Velindre - DATA
CORP 2022 - 025 - Information in relation to sexual assault charges
 CORP 2022 - 025 - Information in relation to sexual assault charges (Word, 1.0Mb)

1. Please provide the number of allegations reported within your trust, clinical commissioning group or other care setting as defined,  of

a) Rape 
b) Sexual assault 
c) Sexual harassment 
d) Sexual misconduct

2. Please advise the location of these offences and or alleged offences broken down by location  Mental Health Unit, Hospital, Other Hospital Setting to be clearly defined.

3. Please provide this data for the last three years, 2019, 2020, 2021 and 2022 to date. 

4. Please provide a month by month  and location

5. Please identify if these allegations are 
    A On Staff carried out by a staff Member
    B On Staff carried out by a patient or visitor
    C By Staff on a Patient 
    D by Staff on a visitor
    E On Staff carried out by a visitor

6. For each of these allegations please advise if a suspect was identified and or arrested 

7. If a suspect was identified and the suspect was identified as a member or staff or a contractor to the trust, CCG or group. What was the outcome?  Was the suspect subsequently arrested, charged or convicted?  Was the suspect subsequently investigated, suspended or dismissed from the Trust. 
 

CORP 2022 - 026 - Information in relation to clinical trials at the Trust
 CORP 2022 - 026 - Information in relation to clinical trials at the Trust (Word, 1.0Mb)

I am trying to understand the level of clinical trials activity that is taking place in the UK. Specifically can you tell me how many commercial clinical trials have been taking place in this hospital trust during 2021?
This could be completed trials, or trials that are ongoing. When I say “commercial trials”, I mean trials that are funded or sponsored by a commercial company such as a pharmaceutical company.
 

CORP 2022 - 029 - Information relating to the incidence and treatment of different types of cancer within Velindre.
 CORP 2022 - 029 - Information relating to the incidence and treatment of different types of cancer within Velindre. (Word, 1.0Mb)

We are investigating the incidence and treatment of different types of cancer in the UK. We would greatly appreciate if you could answer the below questions:
1. How many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents:
•    Carboplatin (monotherapy or in combination with 5-FU)
•    Cisplatin (monotherapy or in combination with 5-FU)
•    Cetuximab with/without chemotherapy 
•    Cetuximab with radiotherapy 
•    Pembrolizumab monotherapy
•    Pembrolizumab with chemotherapy
•    Nivolumab 
•    Docetaxel (monotherapy or in combination with 5-FU)
•    Fluorouracil (5FU)
•    Radiotherapy only
•    Other
2. For the patients treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the therapies listed in the first question, please provide:
•    Total number of head and neck cancer patients
•    Number of locally advanced head and neck cancer patients
•    Number of recurrent and/or metastatic head and neck cancer patients
3. How many Urothelial cancer patients have been treated in the past 3 months with the following agents:
•    Atezolizumab 
•    Carboplatin with Gemcitabine 
•    Carboplatin single or in any other combination 
•    Cisplatin with Gemcitabine 
•    Cisplatin single or in any other combination 
•    Nivolumab 
•    Pembrolizumab 
•    Any other regimen including Paclitaxel 
•    Any other chemotherapy regimen 
•    Other active systemic anti-cancer therapy [please state] 
•    Palliative care only 
4. Does your trust participate in any ongoing clinical trials for the treatment of urothelial cancer? If so, can you please provide the name of each trial along with the number of patients taking part?

CORP 2022 - 030 - Information in relation to cleaning contracts - update request
 CORP 2022 - 030 - Information in relation to cleaning contracts - update request (Word, 1.0Mb)

I would like the organisation to review my freedom of information request below, that’s focused around contract data for services around facilities management.
1. Office and building cleaning – Service contract that is focused around office, commercial and building cleaning services.
 

CORP 2022 - 030 - Information in relation to cleaning contracts - update request - DATA
 CORP 2022 - 030 - Information in relation to cleaning contracts - update request - DATA (Excel, 20Kb)

CORP 2022 - 030 - Information in relation to cleaning contracts - update request - DATA

CORP 2022 - 031 - Information in relation to the incidence and treatment of prostate cancer within Velindre
 CORP 2022 - 031 - Information in relation to the incidence and treatment of prostate cancer within Velindre (Word, 1.0Mb)

We are looking to understand the incidence and treatment of prostate cancer in the UK. We would greatly appreciate if you could answer the following questions:

1. Please provide the total number of patients treated in the last 3 months with any systemic anti-cancer treatment for: 
•    Prostate cancer (any stage)
•    Metastatic prostate cancer

2. How many patients were treated for prostate cancer (any stage) in the past 3 months with: 
•    Androgen Deprivation Therapy (ADT) standalone 
•    Abiraterone (Zytiga) in combination with any ADT 
•    Abiraterone (Zytiga) - no ADT 
•    Enzalutamide (Xtandi) in combination with any ADT 
•    Enzalutamide (Xtandi) - no ADT 
•    Apalutamide (Erleada) in combination with any ADT 
•    Darolutamide (Nubeqa) in combination with any ADT 
•    Cabazitaxel (Jevtana) 
•    Docetaxel in combination with any ADT 
•    Docetaxel – no ADT 
•    Degarelix (Firmagon) 
•    Olaparib (Lynparza)

3. How many metastatic prostate cancer patients were treated in the past 3 months with: 
•    Androgen Deprivation Therapy (ADT) standalone 
•    Apalutamide (Erleada) in combination with any ADT 
•    Docetaxel in combination with any ADT 
•    Docetaxel – no ADT

CORP 2022 - 031 - information in relation to the incidence and treatment of prostate cancer within Velindre - DATA
CORP 2022 - 032 - Information in relation to hosting contracts.
 CORP 2022 - 032 - Information in relation to hosting contracts. (Word, 1.0Mb)

Further to the original Hosting request, the contract below has expired. Please provide the current status.
ConnectWise - cloud contract
Phishing Tackle - cloud contract
I wish to submit a request to the organisation around their hosting contract(s) with 3rd party providers.
The type of contract I wish to see is below:
1. Dedicated hosting- Managed environment
2. Co-Location- hosting allows a business to still own their own server equipment; however, instead of storing it in their own data centre, they instead are able to store it in rented space in a colocation hosting centre.
3. Cloud Hosting- Cloud hosting services provide hosting for websites on virtual servers, which pull their computing resources from extensive underlying networks of physical web servers.

Not all of these will be applicable to the organisation.

For the different types of hosting services, can you provide me with the following information:
1. Type of hosting – Dedicated, Co-Location, Cloud Hosting, Other?
2. Who is the supplier of the contract? If possible can you also provide me with the name of the vendor, if applicable?
3. What is the annual contract value for each contract?
4. What type of cloud environment?
Private Cloud- a distinct and secure cloud based environment in which only the specified client can operate. 
Public Cloud - where cloud services are provided in a virtualized environment, constructed using pooled shared physical resources, and accessible over a public network such as the internet.
Hybrid- integrated cloud service utilising both private and public clouds to perform distinct functions within the same organisation.
5. What is the original start date of the contract agreement? If there are more than one contract please provide me with the start date for each contract.
6. What is the actual expiry date of the contract agreement? If there are more than one contract please provide me with the expiry date for each contract.
7. When will the organisation plan to review this contract? If there are more than one contract please provide me with the review date for each contract.
8. What is the contract period in years? Please include whether the agreement has any extension periods?
9. What services are provided under the contract? Please do not put hosting information such as web hosting, file storage, hosted application. The more information the better,
10. Can you please provide me with the contract officer responsible for this contract? Complete contact details if possible name, title, contact email and number.

CORP 2022 - 033 - Information relating to the Welsh Infected Blood Enquiry
 CORP 2022 - 033 - Information relating to the Welsh Infected Blood Enquiry (Word, 1.0Mb)

Under the terms of the Freedom of Information Act 2000, please could you provide me with the total number of individuals registered with Wales Infected Blood Support Scheme between 1 July 2017 and 28 February 2022 and the total number of those registered who died in the same period.

CORP 2022 - 034 - Information relating to the incidence and treatment of oesophageal and gastric cancer within Velindre
CORP 2022 - 034 - Information relating to the incidence and treatment of oesophageal and gastric cancer within Velindre - DATA
CORP 2022 - 035 - Information on who is responsible for managing the trust's environmental and sustainability policy within the Trust
CORP 2022 - 036 Information on how many plastic laminating pouches/sleeves were purchased 2019/2020/2021
 CORP 2022 - 036 Information on how many plastic laminating pouches/sleeves were purchased 2019/2020/2021 (Word, 1.0Mb)

Could you please provide me the information on how many plastic laminating pouches/sleeves were purchased in:

- 2019
- 2020
- 2021

Thank you for your assistance in this, these numbers will help to be able to identify opportunities towards net zero.
 

CORP 2022 - 037 - Information in relation to Patient Initiated-Follow Up (PIFU) at Velindre
CORP 2022 - 037 - Information in relation to Patient Initiated-Follow Up (PIFU) at Velindre - DATA
CORP 2022 - 038 - Information in relation to telecoms and network contracts at Velindre
CORP 2022 - 038 - Information in relation to telecoms and network contracts at Velindre - DATA
CORP 2022 - 039 - Information in relation to rostering and job planning at Velindre